一个简单的工具来评估艾滋病毒护理对数据可用性差距的环境 (ESTIHIV) 的有效性
Dorthe Raben1, Marie L Jakobsen1, Jamina Trajanovska2
1CHIP, Rigshospitalet, University of Copenhagen, Denmark.
PloS one
|January 29, 2025
概括
ESTIHIV是一个新的工具,可以帮助艾滋病毒诊所估计接受抗逆转录病毒治疗 (ART) 和病毒抑制 (VS) 患者的数量. 这种工具可以更好地监控艾滋病毒护理计划,即使在有限的IT基础设施.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 医疗信息学 医疗信息学
背景情况:
- 许多艾滋病毒诊所在IT基础设施方面扎,这阻碍了对艾滋病毒护理监测的数据报告.
- 对接受抗逆转录病毒治疗 (ART) 和病毒抑制 (VS) 个体的准确数据对于评估艾滋病毒治疗计划至关重要.
研究的目的:
- 开发和验证ESTIHIV,用于监测艾滋病毒持续护理的估计工具.
- 确定使用随机抽样对ART和VS患者进行代表性估计所需的最小数据.
主要方法:
- 开发了ESTIHIV估计工具.
- 进行了一项概念验证研究,包括来自七个国家的七个诊所的8852名参与者 (2017年).
- 使用RESPOND队列 (26,426名来自27个国家的参与者,2019年数据) 验证了该工具.
主要成果:
- 概念验证:93.8%使用ART,76.7%使用VS.
- 验证:在ART上达到97.8%,在VS上达到91.5%.
- 在ESTIHIV估计和ART和VS的完整队列数据之间的良好一致性.
结论:
- 对于诊所来说,ESTIHIV提供了一种可靠的方法来估计ART和VS数据.
- 该工具有助于有效监测艾滋病毒护理计划的绩效,特别是在资源有限的环境中.
相关概念视频
Sexually Transmitted Infections
261
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
261
Statistical Software for Data Analysis and Clinical Trials
481
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
481
Comparing the Survival Analysis of Two or More Groups
134
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
134
Kaplan-Meier Approach
82
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
82
Statistical Methods for Analyzing Epidemiological Data
293
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
293


